Interestingly, HSP90 overexpression has been observed in numerous cancers, including breast, urinary, ovarian, lung, colon, esophageal, ovarian, endometrial, bone, and prostate cancers [10,11]. Here, HSP90AB1 is linked to prostate carcinoma.